Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 1:51 AM ET

Biotechnology

Company Overview of NGM Biopharmaceuticals, Inc.

Company Overview

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, discovers and develops transformational biologics for the treatment of cardio-metabolic diseases, hepatic diseases, and cancers. It offers NGM282, a phase 2 clinical development products that is used for the treatment of gastric bypass surgery on metabolic and bile acid-related diseases. The company also develops novel drug candidates for the treatment of Type 2 diabetes and obesity. In addition, it offers various drug discovery programs that include enteroendocrine cells, beta-cell regeneration, and intestinal microbiome programs. The company has strategic partnerships with MedImmune/AstraZeneca, Daiichi Sankyo, and JDRF. NGM Biopha...

630 Gateway Boulevard

South San Francisco, CA 94080-7014

United States

Founded in 2007

Phone:

650-243-5555

Fax:

650-583-1646

Key Executives for NGM Biopharmaceuticals, Inc.

Chief Executive Officer and Director
Age: 55
President
Age: 42
Founder, Chief Scientific Officer and Director
Age: 52
Chief Financial Officer
Chief Operating Officer and Vice President
Compensation as of Fiscal Year 2015.

NGM Biopharmaceuticals, Inc. Key Developments

NGM Biopharmaceuticals, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 09:00 AM

NGM Biopharmaceuticals, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 09:00 AM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Jeff Jonker, President.

NGM Biopharmaceuticals, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 through Oct-21-2015

NGM Biopharmaceuticals, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 through Oct-21-2015. Venue: Parc 55 Hotel, San Francisco, California, United States. Presentation Date & Speakers: Oct-20-2015, Jeff Jonker, President. Oct-21-2015, David Woodhouse, Chief Financial Officer.

NGM Biopharmaceuticals, Inc. Presents at Boston CEO Conference, May-27-2015 01:00 PM

NGM Biopharmaceuticals, Inc. Presents at Boston CEO Conference, May-27-2015 01:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Jeff Jonker, President.

Similar Private Companies By Industry

Company Name Region
Celliance Corporation United States
Enterologics, Inc. United States
MSC Regenos United States
Cool-Bio, Inc. United States
Advenchen Laboratories, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
February 23, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NGM Biopharmaceuticals, Inc., please visit www.ngmbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.